NurExone Biologic
EV-based Drug Platform to Treat Damage in the Central Nerve System
Active
Public
Startup
Haifa
Founded 2020-01
Nurexone is aiming to revolutionize recovery from nervous system injuries by regenerating and rewiring of neurons. The company is developing a revolutionary biological extracellular vesicles-based technology drug platform to treat damage in the Central Nerve System (CNS). NurExone’s novel approach to SCI treatment is based on the perspective that intranasal…
SectorHealth Tech & Life Sciences
StagePublic
Total raised$2.8M
Employees26
Founded2020-01
HQHaifa
Patents1
Confidence92
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals